Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02080117
Other study ID # 2013-12-089
Secondary ID
Status Completed
Phase N/A
First received March 4, 2014
Last updated April 24, 2017
Start date January 2014
Est. completion date December 2016

Study information

Verified date April 2017
Source Samsung Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

It is required to establish an adequate definition of delayed graft function in deceased donor kidney transplantation. We attempt to compare various definitions of delayed graft function and find the definition that can predict graft function survival best in deceased donor kidney transplantation.


Description:

Delayed graft function after kidney transplantation has been reported to be an important predictor for poor short and long-term survival. Delayed graft function increases post-transplantation morbidity, hospital stay, and incidence of premature graft failure. However, the definition of delayed graft function varies and more than ten definitions have been used in previous studies. Although the definition using dialysis requirements during seven days after transplantation has been used most frequently, dialysis may be required without any evidence of renal damage during one week after transplantation. Furthermore, the incidence of delayed graft function in living donor kidney transplantation using this definition has been reported to be relatively low (as low as 1.6%) compared with the incidence in deceased donor kidney transplantation (up to 50%). Therefore, it is required to establish a better definition of delayed graft function in deceased donor kidney transplantation. We attempt to compare various definitions of delayed graft function in deceased donor kidney transplantation and find the definition that can predict graft function survival best in deceased donor kidney transplantation.


Recruitment information / eligibility

Status Completed
Enrollment 800
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- patients who underwent living or deceased donor kidney transplantation between 2008 and 2013

Exclusion Criteria:

- incomplete data of postoperative creatinine during ten days after transplantation or postoperative urine output during three days after transplantation

- patients who underwent retransplantation

- patients who expired for reasons other than kidney transplantation

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
kidney transplantation, living or deceased donor


Locations

Country Name City State
Korea, Republic of Samsung Medical Center Seoul

Sponsors (1)

Lead Sponsor Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Other graft survival graft survival one month, six month, and one year after transplantation one month, six month, and one year after transplantation
Other Mortality Mortality after one month, six month, and one year after transplantation one month, six month, and one year after transplantation
Other immediate graft function immediate graft function after eight days after transplantation (defined as serum creatinine decrease less than 70% of preoperative value) after eight days after transplantation
Other slow graft function slow graft function at eight days after transplantation (defined as serum creatinine greater than 70% of preoperative value) at eight days after transplantation
Primary delayed graft function as defined by dialysis requirements within one week after transplantation delayed graft function as defined by dialysis requirements within one week after transplantation during 7 days after transplantation
Secondary delayed graft function as defined by urine output less than1200 ml during first day after transplantation delayed graft function as defined by urine output less than1200 ml during first day after transplantation during 24 hours after transplantation
Secondary delayed graft function as defined by serum creatinine decrease less than 10% during 48 hours after transplantation delayed graft function as defined by serum creatinine decrease less than 10% during 48 hours after transplantation during 48 hours after transplantation
Secondary delayed graft function as defined by creatinine greater than 2.5 mg/dL at ten days after transplantation delayed graft function as defined by creatinine greater than 2.5 mg/dL at ten days after transplantation after ten days after transplantation
Secondary delayed graft function as defined by creatinine clearance less than 10 ml/min/1.73m2 during 24 hours after transplantation delayed graft function as defined by creatinine clearance less than 10 ml/min/1.73m2 during 24 hours after transplantation during 24 hours after transplantation
Secondary delayed graft function as defined by creatinine did not decrease less than preoperative value delayed graft function as defined by creatinine did not decrease less than preoperative value during one week after transplantation
See also
  Status Clinical Trial Phase
Recruiting NCT06051812 - Proteinuria and Renal Perfusion in Renal Transplant Recipients
Completed NCT03536858 - Social Networks and Renal Education: Promoting Transplantation N/A
Recruiting NCT05459337 - Multidisciplinary Support to Access Living Donor Kidney Transplant (MuST AKT) N/A
Active, not recruiting NCT04666545 - Multidisciplinary Support To Access Living Donor Kidney Transplant-Pilot N/A
Recruiting NCT03943238 - TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation Phase 1